Having trouble viewing this email? View in your browser.


25 October 2022

Pre-ECCMID joint event
on global AMR strategy

ESCMID and the Global Leaders Group on Antimicrobial Resistance will co-host a high-level symposia/conference aimed at strengthening the links between research, policy, and practice to develop sustainable solutions and a broader AMR research agenda. Join with world leaders, policy makers, civil servants and renowned scientists at the live event on
14 April 2023 at 15:00-18:30 CEST onsite. The event will also be broadcast live on ESCMID YouTube for free.



1 November 2022 | Course registration deadline

Getting to hepatitis B cure: Is it possible?


9 November 2022 | Deadline

CMI Readership Survey


16 November 2022 | Deadline

Abstract submission for the TAE Research Bites


30 November 2022 | Deadline

Regular ECCMID 2023 abstract submission


New Ecraid article published

ECRAID-Base is building a pan-European sustainable network for harmonized large-scale clinical research studies for infectious diseases. The project is a consortium of 19 partner organisations including ESCMID. They have released a new article introducing the teams and objectives throughout the project.


ISAC/ESCMID symposium at ICC 2022

ESCMID president Annelies Zinkernagel will be presenting in the ISAC/ESCMID joint symposium during the 32nd ICC2022 taking place Monday 28 November 2022 at 17:30-19:00 local time in Perth, Australia (UTC+8). Learn more and register on the event website.


International Congress of Infectious
Diseases highlight

The International Congress on Infectious Diseases 2022 features an expanded range of sessions by bringing the One Health aspect to the world of clinical infectious diseases and microbiology. Join on Day 1 for the first session “Overcoming the Pandemic: National COVID-19 Responses” featuring ESCMID Scientific Affairs Subcommittee member Mary Horgan!


IMMEM XIII poster series on YouTube

We are releasing a new series on the ESCMID YouTube channel featuring poster presentations from IMMEM XIII. Watch as these young researchers explore the depths of their work in epidemiology. Check out the playlist and subscribe to the ESCMID channel for more content and regular updates.


Performance of lipid fingerprint by routine MALDI-ToF for the diagnosis of Mycobacterium tuberculosis complex species

EMA’s human medicines committee (CHMP) has adopted a positive opinion for Takeda`s Dengue Tetravalent Vaccine


ESCMID Executive Office
Gerbergasse 14
4001 Basel

Phone +41 61 508 0150


The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.